Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Int J Pharm. 2021 Jan 22;596:120206. doi: 10.1016/j.ijpharm.2021.120206

Fig. 6.

Fig. 6.

In vitro dissolution profiles of lopinavir (LPV) (A) and ritonavir (RTV) (B) from LPV/RTV nanoparticle (NP) combination (4/1, w/w) and Kaletra® tested in 0.1 N HCl (pH 1.2) for 2 hr and in PBS (pH 6.8) for another 6 hr in a water bath shaker with a rotation speed of 100 rpm at 37 °C (n = 3).